You are here

Our science / Clinical Trials / Find a Trial / NCT00712504

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Back to Search Print Save as PDF Bookmark Trial

NCT00712504

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35233-2115 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Advanced Solid Tumors, Non Small Cell Lung Cancer
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Advanced solid tumor malignancy ECOG 0 or 1

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Prior treatment with with high-dose chemotherapy requiring stem cell rescue Prior
irradiation to ?25% of the bone marrow (e.g. whole pelvis=25%) Patients with centrally
located lung lesions unless recently treated with radiotherapy

NCT00712504
Pfizer
Completed
Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Advanced Solid Tumors, Metastatic Solid Tumors
A Dose Escalation Study of PF‑06939999 in Participants With Advanced or Metastatic Solid Tumors.
NCT03854227
All Genders
18+
Years
Multiple Sites
Advanced Solid Tumors
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
NCT02997176
All Genders
18+
Years
Multiple Sites
Advanced Solid Tumors
An Open-Label Pharmacokinetics and Safety Study of Talazoparib
NCT02997163
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now